Kefir Green Tea Bacterial Culture for Dermatitis and Wound Healing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current skin disorder drugs for suppressing dermatitis development and accelerating skin wound healing often come with significant side effects and limited safety, particularly for long-term use or in sensitive individuals, and natural alternatives with high efficacy and versatility are lacking.

Innovation Solution

Bacterial cultures prepared by culturing bacteria from kefir grains in the presence of green tea, which are safe and effective in suppressing dermatitis development and accelerating skin wound healing, are used in topical drugs, skin disorder drugs, cosmetics, and orally administered drugs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If strong steroid topical drugs are used to suppress dermatitis development and accelerate wound healing, then the therapeutic effect is improved, but side effects such as osteoporosis, arteriosclerosis, growth depression, and skin irritation occur

Engineering Contradiction:
Improvetherapeutic effectVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent replaces long-term steroid therapy with a short-term bacterial culture treatment that achieves therapeutic effects without the cumulative side effects of prolonged steroid use. The bacterial culture acts as a temporary, natural therapeutic agent that does not accumulate harmful effects in the body.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the fundamental parameter of the therapeutic agent from synthetic steroids to natural bacterial cultures. This parameter change transitions the treatment from a high-efficacy but high-risk approach to a lower-risk natural alternative that still provides effective dermatitis suppression and wound healing acceleration.

Inventive Principle:
Principle #35Parameter changes

2Object-generated harmful factors

If non-steroid topical drugs are used to reduce side effects, then safety is improved, but anti-inflammatory effect becomes lower and skin rash and irritation are strongly sensed

Engineering Contradiction:
Improveside effectsVSAvoidanti-inflammatory effect
Core Design Contradiction:
Object-generated harmful factorsVSReliability

Solution Approach 1:

The patent uses a composite approach by combining multiple bacterial strains (Lactobacillus casei and Lactobacillus acidophilus) with green tea extract to create a synergistic formulation. This composite natural preparation provides both anti-inflammatory effects and safety, overcoming the limitation of single non-steroid drugs that lack sufficient efficacy.

Inventive Principle:
Principle #40Composite materials

3Reliability

If Tacrolimus hydrate is used for atopic dermatitis treatment, then immunosuppressive effect is achieved, but skin irritation occurs and safety is not confirmed for infants and children

Engineering Contradiction:
Improveimmunosuppressive effectVSAvoidskin irritation and safety concerns
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent replaces the potentially harmful long-term immunosuppressant with a short-term natural bacterial culture treatment. The bacterial culture provides immunomodulatory effects without the confirmed safety issues of Tacrolimus hydrate in vulnerable populations like infants and children.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The bacterial culture acts as a natural intermediary that modulates the immune system gently without the harsh effects of pharmaceutical immunosuppressants. This intermediary approach provides immunomodulation suitable for sensitive populations including infants, children, and pregnant women.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Object-generated harmful factors

If natural substances are used as skin disorder drugs, then safety is improved, but therapeutic effect and versatility are limited

Engineering Contradiction:
ImprovesafetyVSAvoidtherapeutic effect
Core Design Contradiction:
Object-generated harmful factorsVSReliability

Solution Approach 1:

The patent creates a composite natural preparation combining specific bacterial strains with green tea extract, enhancing the therapeutic effect beyond what single natural substances can provide. This composite formulation maintains the safety of natural substances while achieving versatility comparable to synthetic drugs.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The bacterial culture preparation demonstrates multi-functionality by effectively treating multiple skin conditions including dermatitis, eczema, and various wound types. This universal applicability overcomes the limitation of natural substances that typically target only specific conditions.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The bacterial cultures effectively suppress skin inflammation and itching while accelerating wound healing without the toxicity or side effects associated with traditional treatments, offering a versatile and safe solution for dermatitis and wound care.

Implementation Method 1

a bacterial culture which is prepared by culturing bacteria from kefir grains in the presence of green tea

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentEP1787651B1Bacterial culture having effects of suppressing dermatitis development and accelarating skin wound healing, and product using the same
Publication Date: 2010.02.10 CARROZZERIA JAPAN
  • EP1787651B1 patent drawingFigure 1
  • EP1787651B1 patent drawingFigure 2
  • EP1787651B1 patent drawingFigure 3

AI summary

A culture prepared by culturing a bacteria group separated from kefir grains and a new species Lactobacillus sp. SIID1719-6b of the family Lactobacillaceae in the presence of green tea and then removing the bacterial cells from the resulting bacterial culture. SIID1719-6b (FERM AP-20062) was deposited at International Patent Organism Depositary, the National Institute of Advanced Industrial Science and Technology, Japan and has been transferred to the international deposition as FERM ABP-10299. The culture has effects of suppressing dermatitis development and accelerating skin wound healing.